Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 9, 2026
Endonovo Therapeutics Market Cap
Endonovo Therapeutics has a market cap or net worth of $180.76 thousand as of November 10, 2026. It is the 51,012th most valuable company in the world and the 7,132nd biggest in the United States.
Market Cap
180.76K
Enterprise Value
n/a
Revenue
255.72K
Global Rank
Country Rank
#7,132 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 180.76K, an increase of 129.10%. That is a compound annual growth rate of 6.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 180.76K | - |
| Dec 31, 2025 | 180.76K | -16.91% |
| Dec 31, 2024 | 217.55K | -92.16% |
| Dec 29, 2023 | 2.77M | -20.72% |
| Dec 30, 2022 | 3.50M | 211.37% |
| Dec 31, 2021 | 1.12M | 127.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nextel Medical | 263.46K |
| RegeneRx Biopharmaceuticals | 260.99K |
| CERo Therapeutics Holdings | 258.13K |
| Regen BioPharma | 251.29K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 192.58K |
| THC Farmaceuticals | 163.18K |
| Sorrento Therapeutics | 163.11K |